Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Steensma

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Mayo Clinic Proceedings|July 25, 2000
LymphadenopathyT M Habermann, D P Steensma
Leukemia|October 15, 2005
On the TRAIL of a new therapy for leukemiaS H Kaufmann, D P Steensma
Blood|May 23, 2001
Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are neededD P Steensma, L Letendre, A Tefferi
Leukemia & Lymphoma|March 26, 2002
Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a reviewD P Steensma, C N Harrison, A Tefferi
Mayo Clinic Proceedings|August 16, 2000
Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasisD P Steensma, A Tefferi, C R Weiler
Mayo Clinic Proceedings|March 13, 2001
Hereditary red blood cell disorders in middle eastern patientsD P Steensma, J D Hoyer, V F Fairbanks
Leukemia Research|September 5, 2001
Myelodysplasia with fibrosis: a distinct entity?D P Steensma, C A Hanson, L Letendre, et al.
Leukemia|September 23, 2006
Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2(V617F) positive, del(5)(q13q33) myelodysplastic syndromeR A Mesa, A Tefferi, C-Yang Li, et al.
Leukemia|August 1, 2017
Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?A M Zeidan, M A Sekeres, J Barnard, et al.
Neurology|November 13, 2008
Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorderN Kumar, P Sandroni, D P Steensma, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Mayo Clinic Proceedings|July 25, 2000
LymphadenopathyT M Habermann, D P Steensma
Leukemia|October 15, 2005
On the TRAIL of a new therapy for leukemiaS H Kaufmann, D P Steensma
Blood|May 23, 2001
Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are neededD P Steensma, L Letendre, A Tefferi
Leukemia & Lymphoma|March 26, 2002
Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a reviewD P Steensma, C N Harrison, A Tefferi
Mayo Clinic Proceedings|August 16, 2000
Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasisD P Steensma, A Tefferi, C R Weiler
Mayo Clinic Proceedings|March 13, 2001
Hereditary red blood cell disorders in middle eastern patientsD P Steensma, J D Hoyer, V F Fairbanks
Leukemia Research|September 5, 2001
Myelodysplasia with fibrosis: a distinct entity?D P Steensma, C A Hanson, L Letendre, et al.
Leukemia|September 23, 2006
Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2(V617F) positive, del(5)(q13q33) myelodysplastic syndromeR A Mesa, A Tefferi, C-Yang Li, et al.
Leukemia|August 1, 2017
Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?A M Zeidan, M A Sekeres, J Barnard, et al.
Neurology|November 13, 2008
Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorderN Kumar, P Sandroni, D P Steensma, et al.
Pageof 4